|
Debbie:
'No benefit from being able to detect cancer recurrence early'.. I would be most grateful if you could let us know how you came to this conclusion.
From my personal experience (yet one more person) it was different. Surely you have heard of new technics that allow to treat tumours that are up to a certain size only (brain, bone). Chemo needs to be broken down by liver so if you wait for it to stop working properly..you will be in for a treat..
However I think that it is difficult to check all stage 1&2 and that the risk from radiation from scans should be weighted against the 60-80% chance of being cured. Irregular TM sounds like a nice compromise from the above paper.
There was no need to restate that it was for primary cancer as oppose to MBC, it was already quite clear from the article.
AA:
Thanks, yep I am still confused about the PR- and its association with TMs too..
Steph I am still not sure that c-Erb2 simply means just Erb2
__________________
35 y/o
June 06: BC stage I
Grade 3; ER/PR neg
Her-2+++; lumpectomies
Aug 06: Stage IV
liver mets: 6 tumours
July 06 to Jan 07: 2*FEC+6*Taxotere; 3*TACE; LITT
March 07- Sept 07: Vaccination trial (phase 2, peptide based) at the UW (Seattle).
Herceptin since 2006
NED til Oct 09
Recurrence Oct 2009: to internal mammary gland since October 2009 missed on Oct and March 2010 scan.. palpable nodes in May 2010 when I realised..
Nov 2011:7 mets to lungs progressing fast failed hercp/tykerb/xeloda combo..
superior vena cava blocked: stent but face remains puffy
April 2012: Teresa Trial, randomised to TDM1
Nov 2012 progressing on TDM1
Dec 2012 blockage of my airways by tumours, obliteration of these blocking tumours breathing better but hoping for more- at mo too many tumours to count in the lungs and nodes.
Dec 2012 Starting new trial S-222611 phase 1b dual egfr her2+ inhibitor.
'Under no circumstances should you lose hope..' Dalai Lama
|